Insider Transactions in Q3 2024 at Ginkgo Bioworks Holdings, Inc. (DNA)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
1,148
-3.84%
|
$6,888
$6.17 P/Share
|
Sep 12
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
316
-5.33%
|
$1,896
$6.17 P/Share
|
Sep 11
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,693
+2.22%
|
-
|
Sep 11
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+5.9%
|
-
|
Aug 02
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
17,486
-7.78%
|
$0
$0.29 P/Share
|
Aug 02
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
63,567
-5.52%
|
$0
$0.29 P/Share
|
Aug 01
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,746
+6.21%
|
-
|
Aug 01
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
108,127
+2.31%
|
-
|
Jul 02
2024
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
49,162
-4.5%
|
$0
$0.33 P/Share
|
Jul 02
2024
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
13,520
-6.48%
|
$0
$0.33 P/Share
|
Jul 01
2024
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
108,126
+2.44%
|
-
|
Jul 01
2024
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,746
+6.66%
|
-
|